Literature DB >> 17035461

The expanding spectrum of Mycobacterium avium complex-associated pulmonary disease.

E Andrew Waller1, Archana Roy, Lisa Brumble, Andras Khoor, Margaret M Johnson, Jeffrey L Garland.   

Abstract

Nontuberculous mycobacteria (NTM) are increasingly recognized as important pulmonary pathogens. Mycobacterium avium intracellulare complex (MAC) causes most lung infections due to NTM. Patients with preexisting lung disease or immunodeficiency are at greatest risk for developing MAC infection. The majority of MAC pulmonary cases, however, occur in immunocompetent elderly women in association with nodular infiltrates and bronchiectasis. More recently, pulmonary disease has also been described in immunocompetent patients after exposure to MAC-contaminated hot tubs. We describe a case of aggressive MAC lung disease in a young immunocompetent female patient without preexisting lung disease whose clinical and pathologic characteristics do not fit into any of these categories and may represent a unique manifestation of MAC lung disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035461     DOI: 10.1378/chest.130.4.1234

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Evaluation of Mycobacterium avium complex clarithromycin susceptibility testing using SLOMYCO Sensititre panels and JustOne strips.

Authors:  N Esther Babady; Leslie Hall; Adeline T Abbenyi; Justin J Eisberner; Barbara A Brown-Elliott; Cody J Pratt; Maria C McGlasson; Keanan D Beierle; Sherri L Wohlfiel; Sharon M Deml; Richard J Wallace; Nancy L Wengenack
Journal:  J Clin Microbiol       Date:  2010-03-24       Impact factor: 5.948

3.  An opportune finding in suspected liver metastases.

Authors:  Joanna J Hurley; Jeffrey Turner; Ian A Campbell; Sunil Dolwani
Journal:  BMJ Case Rep       Date:  2011-02-24

4.  Aerosolized amikacin in patients with difficult-to-treat pulmonary nontuberculous mycobacteriosis.

Authors:  A Safdar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-25       Impact factor: 3.267

5.  High-resolution CT of nontuberculous mycobacteria pulmonary infection in immunocompetent, non-HIV-positive patients.

Authors:  R Polverosi; A Guarise; E Balestro; A Carloni; G Dalpiaz; B Feragalli
Journal:  Radiol Med       Date:  2009-12-14       Impact factor: 3.469

Review 6.  Tuberculosis and nontuberculous mycobacterial infections in older adults.

Authors:  Neil W Schluger
Journal:  Clin Chest Med       Date:  2007-12       Impact factor: 2.878

7.  Integrative immunoinformatics for Mycobacterial diseases in R platform.

Authors:  Rupanjali Chaudhuri; Deepika Kulshreshtha; Muthukurussi Varieth Raghunandanan; Srinivasan Ramachandran
Journal:  Syst Synth Biol       Date:  2014-02-15

8.  Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.

Authors:  Kala K Davis; Peter N Kao; Susan S Jacobs; Stephen J Ruoss
Journal:  BMC Pulm Med       Date:  2007-02-23       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.